Multiplex PCR assay-Directly on Respiratory samples:Introduction, Principle, Clinical Significance, and Keynotes

Introduction

Respiratory tract infections are caused by a wide range of pathogens, including viruses, bacteria, and fungi. Conventional diagnostic methods such as culture, microscopy, and antigen detection are time-consuming and often lack sensitivity. Multiplex polymerase chain reaction (PCR) assays, applied directly to respiratory samples (sputum, bronchoalveolar lavage, nasopharyngeal swabs, tracheal aspirates), allow for rapid, simultaneous detection of multiple pathogens within a single reaction. This technique is especially valuable in critical care, oncology, transplant, and pediatric populations, where timely and accurate diagnosis influences clinical outcomes.

Principle

• Sample Processing: Respiratory specimens undergo nucleic acid extraction to release microbial DNA/RNA.
• Multiplex PCR Reaction: Multiple sets of pathogen-specific primers and probes are included in the same PCR mixture.
• Amplification: Thermal cycling amplifies genetic targets simultaneously.
• Detection: Real-time PCR (qPCR) with fluorescent probes or endpoint detection using microarrays, bead-based systems, or capillary electrophoresis allows identification of multiple pathogens at once.
• Controls: Internal controls prevent false negatives, while cross-reactivity is minimized through optimized primer/probe design.

Clinical Significance

• Rapid Diagnosis: Provides results within hours compared to days with traditional cultures.
• Comprehensive Detection: Identifies co-infections (e.g., viral + bacterial, fungal + bacterial) in respiratory disease.
• Guides Therapy: Enables targeted antimicrobial/antifungal/antiviral treatment, reducing unnecessary broad-spectrum use.
• Outbreak Management: Assists in early detection of epidemics (e.g., influenza, SARS-CoV-2, RSV).
• Immunocompromised Patients: Particularly useful in oncology, transplant, and ICU settings where atypical pathogens and mixed infections are common.
• Limitations: May detect colonization or non-viable organisms; cannot provide antimicrobial susceptibility results (must be combined with culture if needed).

Keynotes

• Multiplex PCR is a highly sensitive and specific method for detecting respiratory pathogens directly from clinical samples.
• Reduces turnaround time and improves patient management, especially in severe pneumonia, viral outbreaks, and fungal lung disease.
• Commercial panels (e.g., BioFire FilmArray, Luminex xTAG, QIAstat-Dx) are widely used in clinical laboratories.
• Best applied as a complementary test with culture, microscopy, and susceptibility testing.
• Challenges include cost, technical complexity, and interpretation of colonization vs true infection.
• Plays a crucial role in the era of precision medicine and antimicrobial stewardship.

Further Readings

1. https://www.journalofinfection.com/article/S0163-4453(23)00134-2/fulltext
2. https://www.bocsci.com/resources/multiplex-pcr-definition-principle-and-application.html
3. https://www.clinicalmicrobiologyandinfection.org/article/S1198-743X(18)30451-8/fulltext
4. https://www.sciencedirect.com/science/article/pii/S0163445323001342
5. https://brieflands.com/articles/jjm-59885
6. https://pmc.ncbi.nlm.nih.gov/articles/PMC4199249/
7. https://pmc.ncbi.nlm.nih.gov/articles/PMC88949/
8. https://pmc.ncbi.nlm.nih.gov/articles/PMC9562540/
9. 0Multiplex%20PCR%20Efficiency,certain%20specific%20targets%20(76).
10. https://www.mdpi.com/2075-4418/14/7/734
11. https://www.mayocliniclabs.com/test-catalog/overview/609409
12. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185397/